Celldex Therapeutics Inc.

NASDAQ: CLDX · Real-Time Price · USD
25.41
0.47 (1.88%)
At close: Aug 15, 2025, 2:41 PM

Celldex Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-10.31 -13.59 -18.6 -23.49
PEG Ratio
0.64 -0.63 -0.4 1.25
PS Ratio
231.80 279.16 886.63 356.16
PB Ratio
2.18 4.48 6.41 3.95
P/FCF Ratio
-10.19 -17.61 -19.8 -26.65
P/OCF Ratio
-10.31 -17.91 -20.15 -27.2
OCF/S Ratio
-22.48 -15.59 -44.01 -13.1
Debt / Equity Ratio
0.01 0.01 0.01 0.01
Quick Ratio
18.91 13.87 17.09 24.87
Current Ratio
18.91 13.87 17.07 24.86
Asset Turnover
0.01 0.01 0.01 0.01
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.21 -0.33 -0.34 -0.17
Return on Assets
-0.2 -0.3 -0.32 -0.16
Return on Invested Capital
-0.26 -0.35 -0.34 -0.16
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 -16.15 -33.9 0.34
Net Profit Margin
-22.49 -20.55 -47.66 -15.16
Pretax Profit Margin
-22.49 -20.55 -47.66 -15.21
Operating Profit Margin
-27.79 -22.45 -48.89 -15.32
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-27.34 -20.2 -44.21 -14.21